ADC Therapeutics (ADCT) Operating Expenses: 2018-2022
Historic Operating Expenses for ADC Therapeutics (ADCT) over the last 5 years, with Dec 2022 value amounting to -$333,535.
- ADC Therapeutics' Operating Expenses rose 163.75% to $50.6 million in Q3 2023 from the same period last year, while for Sep 2023 it was $38.9 million, marking a year-over-year increase of 115.38%. This contributed to the annual value of -$333,535 for FY2022, which is 12.82% down from last year.
- Per ADC Therapeutics' latest filing, its Operating Expenses stood at -$333,535 for FY2022, which was down 12.82% from -$295,637 recorded in FY2021.
- In the past 5 years, ADC Therapeutics' Operating Expenses ranged from a high of -$121,739 in FY2019 and a low of -$333,535 during FY2022.
- Moreover, its 3-year median value for Operating Expenses was -$295,637 (2021), whereas its average is -$282,812.
- Per our database at Business Quant, ADC Therapeutics' Operating Expenses increased by 4.20% in 2019 and then plummeted by 80.11% in 2020.
- Yearly analysis of 5 years shows ADC Therapeutics' Operating Expenses stood at -$127,081 in 2018, then grew by 4.20% to -$121,739 in 2019, then crashed by 80.11% to -$219,263 in 2020, then slumped by 34.83% to -$295,637 in 2021, then fell by 12.82% to -$333,535 in 2022.